Page 102 - GPD-4-3

Gene & Protein in Disease ABCA12 gene in Harlequin ichthyosis

StatPearls Publishing; 2025. Available from: https://www. from: https://my.clevelandclinic.org/health/diseases/
ncbi.nlm.nih.gov/books/nbk560492 [Last accessed on harlequin-ichthyosis [Last accessed on 2025 Jan 26].
2025 Jan 26].
14. Jacobi A, Mayer A, Augustin M. Keratolytics and emollients
4. Kelsell DP, Norgett EE, Unsworth H, et al. Mutations and their role in the therapy of psoriasis: A systematic
in ABCA12 underlie the severe congenital skin disease review. Dermatol Ther (Heidelb). 2015;5(1):1-18.
harlequin ichthyosis. Am J Hum Genet. 2005;76(5):794-803.
doi: 10.1007/s13555-015-0068-3
doi: 10.1086/429844
15. Lainingwala AC, Gajula S, Fatima U, et al. A unique case of
5. Craiglow BG. Ichthyosis in the newborn. Semin Perinatol. harlequin ichthyosis in the tertiary health care system in a
2013;37(1):26-31. rural Area. Cureus. 2023;15(8):e43342.
doi: 10.1053/j.semperi.2012.11.001 doi: 10.7759/cureus.43342
6. Bouwstra JA, Nădăban A, Bras W, MCabe C, Bunge A, 16. DiGiovanna JJ, Mauro T, Milstone LM, Schmuth M,
Gooris GS. The skin barrier: An extraordinary interface Toro JR. Systemic retinoids in the management of ichthyoses
with an exceptional lipid organization. Prog Lipid Res. and related skin types. Dermatol Ther. 2013;26(1):26-38.
2023;92:101252.
doi: 10.1111/j.1529-8019.2012.01527.x
doi: 10.1016/j.plipres.2023.101252
17. Retinol Intoxication - an Overview. Science Direct Topics.
7. Haller JF, Cavallaro P, Hernandez NJ, et al. Endogenous Available from: https://www.sciencedirect.com/topics/
β-glucocerebrosidase activity in Abca12−/−epidermis medicine-and-dentistry/retinol-intoxication [Last accessed
elevates ceramide levels after topical lipid application but does on 2025 Jan 26].
not restore barrier function. J Lipid Res. 2014;55(3):493-503.
18. Parikh K, Brar K, Glick JB, Flamm A, Glick SA. A case
doi: 10.1194/jlr.M044941 report of fatal harlequin ichthyosis: Insights into infectious
and respiratory complications. JAAD Case Rep. 2016;2(4):
8. Meyts I, Bosch B, Bolze A, et al. Exome and genome
sequencing for inborn errors of immunity. J Allergy Clin 301-303.
Immunol. 2016;138(4):957-969. doi: 10.1016/j.jdcr.2016.06.011
doi: 10.1016/j.jaci.2016.08.003 19. Sharma G, Sharma AR, Bhattacharya M, Lee SS,
Chakraborty C. CRISPR-Cas9: A preclinical and clinical
9. Baumgartner C, Mátyás G, Steinmann B, Eberle M, Stein JI,
Baumgartner D. A bioinformatics framework for genotype- perspective for the treatment of human diseases. Mol Ther.
phenotype correlation in humans with Marfan syndrome 2021;29(2):571-586.
caused by FBN1 gene mutations. J Biomed Inform. doi: 10.1016/j.ymthe.2020.09.028
2006;39(2):171-183.
20. Foley E, Robinson A, Maloney M. Skin substitutes and
doi: 10.1016/j.jbi.2005.06.001 dermatology: A review. Curr Derm Rep. 2013;2(2):101-112.
10. King AD, Deirawan H, Klein PA, Dasgeb B, Dumur CI, doi: 10.1007/s13671-013-0044-z
Mehregan DR. Next-generation sequencing in dermatology. 21. Anish S. Skin substitutes in dermatology. Indian J Dermatol
Front Med (Lausanne). 2023;10:1218404.
Venereol Leprol. 2015;81:175.
doi: 10.3389/fmed.2023.1218404
doi: 10.4103/0378-6323.152288
11. Buermans HP, Den Dunnen JT. Next generation sequencing 22. Chakraborty A. Bathing practices in dermatology: Uses
technology: Advances and applications. Biochim Biophys and implications for patient management. Indian Dermatol
Acta. 2014;1842(10):1932-1941.
Online J. 2023;14(5):686-691.
doi: 10.1016/j.bbadis.2014.06.015
doi: 10.4103/idoj.idoj_40_23
12. Tsivilika M, Kavvadas D, Karachrysafi S, Sioga A, 23. Cortés H, Cariño-Calvo L, Reyes-Hernández OD, et al. High
Papamitsou T. Management of harlequin ichthyosis: A brief levels of anxiety, depression, risk of suicide, and implications
review of the recent literature. Children (Basel). 2022;9(6):893.
for treatment in patients with lamellar ichthyosis. Healthcare
doi: 10.3390/children9060893 (Basel). 2023;11(14):2071.
13. What Is Harlequin Ichthyosis? Cleveland Clinic. Available doi: 10.3390/healthcare11142071

Volume 4 Issue 3 (2025) 7 doi: 10.36922/GPD025050009